NCT02716259

Brief Summary

The purpose of this study is to investigate whether basic periodontal therapy aim to reduce subgingival levels of Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans, has an impact on the vascular function of patients suffering from established cardiovascular disease.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 19, 2016

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

March 17, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 23, 2016

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 19, 2020

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 20, 2020

Completed
Last Updated

May 9, 2024

Status Verified

May 1, 2024

Enrollment Period

4 years

First QC Date

March 17, 2016

Last Update Submit

May 7, 2024

Conditions

Keywords

PeriodontitisCardiovascular diseasesBacteremiaScaling and root planingFlow-mediated dilationcarotid intima-media thicknessPorphyromonas gingivalisAggregatibacter actinomycetemcomitans

Outcome Measures

Primary Outcomes (1)

  • Flow mediated dilation of the brachial artery

    Endothelium-dependent vasodilatation of the brachial artery assessed by means of ultrasound imaging with the use of a 7-MHz linear probe and vessel diameter measurements. Dilatation was quantified as the change in percentage form a baseline measurement and a second measurement taken after 5 minutes of flow ischemia induced with a sphygmomanometer cuff placed on the forearm.

    Day 0 (Baseline), Day 90, Day 180

Secondary Outcomes (13)

  • Carotid artery atherosclerosis

    Day 0 (Baseline), Day 90, Day 180

  • Periodontal pocket probing depth

    Day 0 (baseline), Day 30, Day 90, Day 180

  • Gingival recession

    Day 0 (baseline), Day 30, Day 90, Day 180

  • Plaque index

    Day 0 (baseline), Day 30, Day 90, Day 180

  • Bleeding on probing index

    Day 0 (baseline), Day 30, Day 90, Day 180

  • +8 more secondary outcomes

Study Arms (2)

Scaling and root planing

EXPERIMENTAL

Two sessions of scaling and root planing under local anesthesia and oral antiseptics (clorhexidine 0.12% rinse),

Procedure: Scaling and root planing

Supragingival prophylaxis

PLACEBO COMPARATOR

Two sessions of supragingival prophylaxis under local anesthesia and an oral rinse with no antiseptic properties.

Procedure: Supragingival prophylaxis

Interventions

Two sessions of scaling and root planing under local anesthesia and clorhexidine rinse twice/day, 15 days

Also known as: Clorhexidine rinse (0.12%) (Perio-Aid, Dentaid, Spain)
Scaling and root planing

Two sessions of scaling and root planing under local anesthesia and sodium fluoride rinse, twice/day, 15 days

Also known as: Sodium fluoride rinse (Fluor-Aid, Dentaid, Spain)
Supragingival prophylaxis

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • (1) patients with established cardiovascular disease (unstable angina or stroke in the previous 3 to 12 months, and left ventricular ejection fraction ≥50%);
  • (2) diagnosis of moderate to severe generalized periodontitis (PD\>5mm and marginal bone loss \>30% on at least 50% of the teeth, according to Tonetti et al. 2007);
  • (3) presence of at least 3 teeth per quadrant.

You may not qualify if:

  • (1) periodontal treatment in the previous year;
  • (2) antibiotic intake in the previous 3 months;
  • (3) smokers of ≥10 cigarettes per day;
  • (4) pregnancy or breast feeding;
  • (5) diabetes mellitus types I or II, with glycosylated hemoglobin values \>7;
  • (6) necrotizing periodontal diseases;
  • (7) HIV infection;
  • (8) chronic intake of NSAID

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Severo Ochoa Hospital

Leganés, Madrid, Spain

Location

Faculty of dentistry, Complutense University Madrid

Madrid, 28040, Spain

Location

Related Publications (2)

  • Tonetti MS, D'Aiuto F, Nibali L, Donald A, Storry C, Parkar M, Suvan J, Hingorani AD, Vallance P, Deanfield J. Treatment of periodontitis and endothelial function. N Engl J Med. 2007 Mar 1;356(9):911-20. doi: 10.1056/NEJMoa063186.

    PMID: 17329698BACKGROUND
  • Molina A, Ambrosio N, Molina M, Montero E, Virto L, Herrera D, Figuero E, Sanz M. Effect of periodontal therapy on endothelial function and serum biomarkers in patients with periodontitis and established cardiovascular disease: a pilot study. Front Oral Health. 2025 Feb 10;6:1488941. doi: 10.3389/froh.2025.1488941. eCollection 2025.

MeSH Terms

Conditions

PeriodontitisCardiovascular DiseasesBacteremia

Interventions

Tooth ExfoliationRoot Planing

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic DiseasesBacterial InfectionsBacterial Infections and MycosesInfectionsSepsisSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Dental Physiological PhenomenaDigestive System and Oral Physiological PhenomenaDental ScalingDental ProphylaxisPeriodonticsDentistrySubgingival CurettagePreventive Dentistry

Study Officials

  • Mariano Sanz, Professor

    Faculty of Dentistry, Complutense University of Madrid

    PRINCIPAL INVESTIGATOR
  • David Herrera, Professor

    Faculty of Dentistry, Complutense University of Madrid

    PRINCIPAL INVESTIGATOR
  • Elena Figuero, Professor

    Faculty of Dentistry, Complutense University of Madrid

    STUDY DIRECTOR
  • María Molina, Doctor

    Servicio de Cardiología, Hospital Universitario Severo Ochoa

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

March 17, 2016

First Posted

March 23, 2016

Study Start

February 19, 2016

Primary Completion

February 19, 2020

Study Completion

February 20, 2020

Last Updated

May 9, 2024

Record last verified: 2024-05

Locations